Publications (original articles or review articles) published in 2014 from OUS - Department of Clinical Cancer Research
17 publications found
Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones
Hum Reprod, 29 (12), 2844-51
DOI 10.1093/humrep/deu274, PubMed 25336703
Comparing effects in regular practice of e-communication and Web-based self-management support among breast cancer patients: preliminary results from a randomized controlled trial
J Med Internet Res, 16 (12), e295
DOI 10.2196/jmir.3348, PubMed 25525672
Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery
J Cancer Surviv, 9 (2), 172-9
DOI 10.1007/s11764-014-0399-6, PubMed 25216609
Is Liver Transplantation an Option in Colorectal Cancer Patients with Nonresectable Liver Metastases and Progression on All Lines of Standard Chemotherapy?
Ann Surg Oncol, 22 (7), 2195-200
DOI 10.1245/s10434-014-4137-0, PubMed 25297902
Site-specific proportion cured models applied to cancer registry data
Cancer Causes Control, 25 (3), 365-73
DOI 10.1007/s10552-014-0337-y, PubMed 24442714
Reirradiation of locally recurrent rectal cancer: a systematic review
Radiother Oncol, 113 (2), 151-7
DOI 10.1016/j.radonc.2014.11.021, PubMed 25613395
Adding intensity-modulated radiotherapy to the pelvis does not worsen the adverse effect profiles compared to limited field radiotherapy in men with prostate cancer at 12-month follow-up
Acta Oncol, 53 (10), 1380-9
DOI 10.3109/0284186X.2014.916042, PubMed 24844918
Biomarkers of treatment toxicity in combined-modality cancer therapies with radiation and systemic drugs: study design, multiplex methods, molecular networks
Int J Mol Sci, 15 (12), 22835-56
DOI 10.3390/ijms151222835, PubMed 25501337
Biomarkers of histone deacetylase inhibitor activity in a phase 1 combined-modality study with radiotherapy
PLoS One, 9 (2), e89750
DOI 10.1371/journal.pone.0089750, PubMed 24587009
Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft
PLoS One, 9 (11), e113278
DOI 10.1371/journal.pone.0113278, PubMed 25419568
Risk matrix for prediction of advanced disease in a population-based study of patients with Crohn's Disease (the IBSEN Study)
Inflamm Bowel Dis, 20 (1), 60-8
DOI 10.1097/01.MIB.0000436956.78220.67, PubMed 24280875
Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors
J Clin Oncol, 32 (6), 571-8
DOI 10.1200/JCO.2013.51.2715, PubMed 24419125
Family caregivers of cancer patients: perceived burden and symptoms during the early phases of cancer treatment
Soc Work Health Care, 53 (3), 289-309
DOI 10.1080/00981389.2013.873518, PubMed 24628120
Localized prostate cancer in Norway, the United States, and Spain: between-country differences of variables before treatment among patients eligible for curative treatment
Clin Genitourin Cancer, 12 (4), e117-25
DOI 10.1016/j.clgc.2013.12.007, PubMed 24524968
Plasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: RESULTS from the NORDIC VII Study
PLoS One, 9 (2), e87746
DOI 10.1371/journal.pone.0087746, PubMed 24498368
Recruiting long-term survivors of European Organisation for Research and Treatment of Cancer phase III clinical trials into quality of life studies: challenges and opportunities
Eur J Cancer, 50 (11), 1957-63
DOI 10.1016/j.ejca.2014.04.018, PubMed 24820932
Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levels
Cancer Immunol Immunother, 64 (2), 173-80
DOI 10.1007/s00262-014-1620-1, PubMed 25319807